On the 30th of June and the 1st of July, Johnson & Johnson Innovation will be organizing two programs: The first program concerns the virtual symposium “Advances in Neuroimmunology: Potential for Novel Therapeutics for CNS Disorders” on 30 June. After the event there will be applications for 1-to-1 meetings for those that may be interested to investigate potential collaboration and partnerships with Johnson & Johnson and Janssen Neuroscience. The second program is titled “Investor Perspective: How Can Partnering with Pharma Impact Startup Success?” during which a panel of investors share their insights on how and when entrepreneurs and start-ups might interact with pharma companies.